Please login to the form below

Not currently logged in
Email:
Password:

Sanofi appoints immunology and inflammation research global head

Dr Frank Nestle also becomes North America chief scientific officer

Sanofi Dr Frank NestleSanofi has appointed Dr Frank Nestle as both the global head of immunology and inflammation research therapeutic area and North America chief executive officer.

Based out of the French firm's Cambridge, Massachusetts office, Dr Nestle will be responsible for developing Sanofi's early stage immunology and inflammations portfolio and driving its scientific intelligence across multiple therapeutic areas in the US.

He joins Sanofi from King's College London, where he was the Mary Dunhill professor and chair of cutaneous medicine and immunotherapy.

Currently, Dr Nestle serves as lead biomarker for the co-diagnostics, imaging and devices cluster at the Biomedical Research Centre and is the outgoing president of the Federation of Clinical Immunology Societies.

He is a fellow of the Academy of Medical Sciences, a senior investigator emeritus at the National Institute for Health Research and has also served as a non-executive director at Guy's and St Thomas' Foundation Trust Hospital.

12th September 2016

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics